Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm, with offices in Shanghai, Hong Kong, and Palo Alto. Our vision is to become the trusted partner for exceptional entrepreneurs seeking smart capital and to build great companies developing breakthrough products that treat diseases and improve human health.
We are long-term thinkers who bet on people, products and quality science.
biopharmaceuticals, human therapeutics, medical devices, and diagnostics
Room 2909-14, 168 Hubin Road, Huangpu District, Shanghai, China.
Room 606-7, St. George's Building, 2 Ice House Street, Central, Hong Kong
2735 Sand Hill Road, Suite 210
Menlo Park, CA 94025
copyright © 2018 Lilly Asia Ventures all rights reserved.